1 – 10 of 168
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2016
- 
                        Mark
        Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy.
    
    - Contribution to journal › Debate/Note/Editorial
 
- 
                        Mark
        Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
    
    - Contribution to journal › Article
 
- 
                        Mark
        The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer.
    
    - Contribution to journal › Article
 
- 
                        Mark
        Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy.
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        The Proteome of Primary Prostate Cancer.
    
    - Contribution to journal › Article
 
- 
                        Mark
        The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Re : Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic Alterations
    
    - Contribution to journal › Debate/Note/Editorial
 
- 
                        Mark
        Re : The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
    
    - Contribution to journal › Debate/Note/Editorial
 
- 2015
- 
                        Mark
        Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    
    - Contribution to journal › Debate/Note/Editorial
 
